MedTrace Logo

Development of an Informed Consent Statement Which Communicates the Risk of Adverse Events Associated With Dry Needling

NCT05560100 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2023-06-13

No results posted yet for this study

Summary

As Dry Needling (DN) continues to see increased use in the clinic, there is a need to establish adverse events that could occur as a result of DN intervention. The adverse events are important to consider when an individual needs to make an informed decision regarding their care. It is important to consider how such information should be presented during the informed consent process to improve an individual's ability to make a sound decision regarding their own personal care.

Conditions

  • Dry Needling

Interventions

OTHER

Nominal Group Technique - 2 to 3 hour virtual meeting

Participants will be invited to a 2-3 online virtual online meeting with the goal of constructing and defining elements for producing a risk statement for dry needling that can be used for informed consent.

Sponsors & Collaborators

  • Youngstown State University

    lead OTHER

Principal Investigators

  • Edmund C Ickert, PhD · Youngstown State University

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-19
Primary Completion
2022-10-31
Completion
2022-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05560100 on ClinicalTrials.gov